NAVBQ (Navidea Biopharmaceuticals) Interest Expense: $-0.61 Mil (TTM As of Sep. 2023)


NAVBQ Navidea Biopharmaceuticals Inc NAVBQ
16 GF Score
Price $0.00
View Full Analysis

What is Navidea Biopharmaceuticals Interest Expense?

Navidea Biopharmaceuticals NAVBQ -90.00% 16 Interest Expense is $-0.61 Mil as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Navidea Biopharmaceuticals's interest expense for the three months ended in Sep. 2023 was $ -0.10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.61 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Navidea Biopharmaceuticals's Operating Income for the three months ended in Sep. 2023 was $ -2.13 Mil. Navidea Biopharmaceuticals's Interest Expense for the three months ended in Sep. 2023 was $ -0.10 Mil. Navidea Biopharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Navidea Biopharmaceuticals  (OTCPK:NAVBQ) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Navidea Biopharmaceuticals's Interest Expense for the three months ended in Sep. 2023 was $-0.10 Mil. Its Operating Income for the three months ended in Sep. 2023 was $-2.13 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was $0.00 Mil.

Navidea Biopharmaceuticals's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Navidea Biopharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Navidea Biopharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals Interest Expense Chart

Navidea Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 0.00 0.00 -0.01 -1.10

Navidea Biopharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.77 -0.25 -0.26 0.00 -0.10
NAVBQ
16GF Score
Navidea Biopharmaceuticals Inc NAVBQ
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Navidea Biopharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.61 Mil mean?
Navidea Biopharmaceuticals (NAVBQ) has a Interest Expense of $-0.61 Mil as of Sep. 2023. Interest Expense is the amount a company pays on its long-term debt. View historical data on Navidea Biopharmaceuticals and its competitors.
Is Navidea Biopharmaceuticals' Interest Expense too high?
Navidea Biopharmaceuticals' current Interest Expense is $-0.61 Mil. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Navidea Biopharmaceuticals' Interest Expense compare to PKBO and RSPI?
Navidea Biopharmaceuticals' Interest Expense of $-0.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Navidea Biopharmaceuticals and its competitors. Navidea Biopharmaceuticals's current Interest Expense is $-0.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Navidea Biopharmaceuticals stock overvalued right now?
Navidea Biopharmaceuticals (NAVBQ) has a current Interest Expense of $-0.61 Mil. The current Interest Expense is $-0.61 Mil. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current Interest Expense is $-0.61 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552
Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
16GF Score

Get the complete analysis for NAVBQ

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price